每經AI快訊，羚(ling)銳(rui)(rui)制藥(yao)（SH 600285，收(shou)盤價：15.74元）3月1日(ri)晚間發布公(gong)(gong)告(gao)稱，河南羚(ling)銳(rui)(rui)集(ji)團有(you)限公(gong)(gong)司持有(you)河南羚(ling)銳(rui)(rui)制藥(yao)股(gu)(gu)(gu)(gu)(gu)份有(you)限公(gong)(gong)司股(gu)(gu)(gu)(gu)(gu)票(piao)約1.22億股(gu)(gu)(gu)(gu)(gu)，占公(gong)(gong)司總(zong)股(gu)(gu)(gu)(gu)(gu)本比(bi)例為(wei)21.47%。本次質押后，羚(ling)銳(rui)(rui)集(ji)團持有(you)公(gong)(gong)司股(gu)(gu)(gu)(gu)(gu)份累計質押數(shu)量約為(wei)6798萬股(gu)(gu)(gu)(gu)(gu)，占其持股(gu)(gu)(gu)(gu)(gu)數(shu)量比(bi)例為(wei)55.81%，占公(gong)(gong)司總(zong)股(gu)(gu)(gu)(gu)(gu)本比(bi)例為(wei)11.98%。截至(zhi)本公(gong)(gong)告(gao)披露日(ri)，羚(ling)銳(rui)(rui)集(ji)團及其一致(zhi)行動人(ren)持有(you)公(gong)(gong)司股(gu)(gu)(gu)(gu)(gu)份約1.46億股(gu)(gu)(gu)(gu)(gu)，占公(gong)(gong)司總(zong)股(gu)(gu)(gu)(gu)(gu)本的(de)25.77%。

2022年1至6月份，羚銳制藥(yao)的營業收(shou)入(ru)構(gou)成為：工業制造占比(bi)99.65%，其他行業占比(bi)0.26%。

羚銳制藥的總經(jing)理、董事長均是(shi)熊(xiong)偉，男，39歲，學(xue)歷背景為碩(shuo)士。

截(jie)至發稿，羚銳制藥市值為89億元。

道達號（daoda1997）“個股趨(qu)勢”提醒：
1. 羚銳制藥近30日內北向資金持股量減少390.20萬股，占流通股比例減少0.69%；
2. 近30日內無機構對羚銳制藥進行調研。
更多個股趨(qu)勢信(xin)息(xi)，請搜索微(wei)信(xin)公眾號“道(dao)達號”，回復“查詢”，領取(qu)免費查詢權限！

每經頭條（nbdtoutiao）——

(記者 蔡鼎)

免責(ze)聲明：本文內容與數(shu)據(ju)僅供參考，不(bu)構(gou)成投(tou)資建議，使用前請核實。據(ju)此操作，風險自擔。